Physical Activity Levels and Functional Improvement in Breast Cancer Survivors (CanEX)

February 17, 2021 updated by: University of New Brunswick

Do Physical Activity Levels Predict Functional Improvements Following a Structured Exercise Program for Women Living With Breast Cancer?

The main objective of our project is to describe what characteristics (e.g., age, current physical activity level) women present when starting the exercise program are potentially associated with an improvement in functional abilities measured with different tests such as the distance you can cover while walking for six minutes.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

The main research objective is to investigate the relationship between baseline physical activity and improvement in physical function, quantified using changes in 6-minute walk test (6MWT) results over the course of the 12-week program. An association is hypothesized to exist between the two variables even when adjusted for weeks into treatment. The goal of the 6MWT is to cover as much distance as possible in six minutes, using as many breaks s necessary. The test is often performed using a 20-meter hallway but requires no specific equipment. A recent study reported that the result of the 6MWT could be used as a measure of the major components of global health in women with breast cancer, making its use in our research especially relevant. Aside from physical functions, baseline characteristics will also be used to determine what characteristics, if any, are associated with health and psychosocial outcomes such as quality of life, social connectedness/support, and mental well-being. The data collected is certain to fill a gap in the literature, and will therefore be likely published in an important journal in the field.

Study Type

Interventional

Enrollment (Anticipated)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • New Brunswick
      • Fredericton, New Brunswick, Canada
        • Recruiting
        • University of New Brunswick
        • Contact:
    • Newfoundland and Labrador
      • St. John's, Newfoundland and Labrador, Canada
        • Recruiting
        • Memorial University of Newfoundland
        • Contact:
    • Prince Edward Island
      • Charlottetown, Prince Edward Island, Canada
        • Recruiting
        • University of Prince Edward Island
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Have received a diagnosis of breast cancer in your lifetime
  • 19 years of age and older
  • Cleared by medical team to participate in the study
  • Have the intention to exercise at the facility for the duration of the study

Exclusion Criteria:

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: SUPPORTIVE_CARE
  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Participant
Participants will answer a series of questionnaires, wear a physical activity tracker (pedometer) and do functional tests (six minute walk test, chair stand test, balance, back scratch, sit and reach, leg strength and hand strength) pre and post.
Participants will exercise twice a week for twelve weeks total.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Walking speed
Time Frame: Pre and post (after 12 weeks)
6-minute walk test (meters walked)
Pre and post (after 12 weeks)
Balance
Time Frame: Pre and post (after 12 weeks)
One leg stand test (seconds)
Pre and post (after 12 weeks)
Strength, Hand grip
Time Frame: Pre and post (after 12 weeks)
Amount of force that can be exerted during grip squeeze (kg)
Pre and post (after 12 weeks)
Strength, Chair stand test
Time Frame: Pre and post (after 12 weeks)
Chair stand test, number of chair stand in 30 seconds
Pre and post (after 12 weeks)
Flexibility, back scratch test
Time Frame: Pre and post (after 12 weeks)
Back scratch test (cm)
Pre and post (after 12 weeks)
Flexibility, sit and reach
Time Frame: Pre and post (after 12 weeks)
Sit and reach test
Pre and post (after 12 weeks)
Physical Activity Level
Time Frame: Pre and post (after 12 weeks)
Pedometer to determine minutes in moderate-vigorous physical activity and steps per day
Pre and post (after 12 weeks)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Attendance
Time Frame: Pre and post (after 12 weeks)
Amount of exercise sessions attended during the 12-week program
Pre and post (after 12 weeks)
Weight
Time Frame: Pre and post (after 12 weeks)
Weight of individual (kg)
Pre and post (after 12 weeks)
Height
Time Frame: Pre and post (after 12 weeks)
Height of individual (cm)
Pre and post (after 12 weeks)
Resting Blood Pressure
Time Frame: Pre and post (after 12 weeks)
Systolic and diastolic blood pressure (mmHg)
Pre and post (after 12 weeks)
Resting Heart Rate
Time Frame: Pre and post (after 12 weeks)
Resting heart rate (beats per minute)
Pre and post (after 12 weeks)
Body-mass Index
Time Frame: Pre and post (after 12 weeks)
Measure of body fat based on height and weight (kg/m^2)
Pre and post (after 12 weeks)
Waist Circumference
Time Frame: Pre and post (after 12 weeks)
Measurement around the waist (cm)
Pre and post (after 12 weeks)
FANTASTIC Lifestyle Checklist
Time Frame: Pre and post (after 12 weeks)
Meaningful improvement above day-to-day variability on the 6MWT
Pre and post (after 12 weeks)
Functional Assessment of Cancer Therapy General (FACT - G)
Time Frame: Pre and post (after 12 weeks)
27-item questionnaire designed to measure four domains of HRQOL in cancer patients: Physical, social, emotional, and functional well-being
Pre and post (after 12 weeks)
Functional Assessment of Cancer Therapy Fatigue (FACT - F)
Time Frame: Pre and post (after 12 weeks)
40-item measure that assesses self-reported fatigue and its impact upon daily activities and function
Pre and post (after 12 weeks)
Depression Anxiety Stress Scales (DASS)
Time Frame: Pre and post (after 12 weeks)
42-item self report instrument designed to measure the three related negative emotional states of depression, anxiety and tension/stress.
Pre and post (after 12 weeks)
Pittsburgh Sleep Quality Index (PSQI)
Time Frame: Pre and post (after 12 weeks)
A self-report questionnaire that assesses sleep quality over a 1-month time interval
Pre and post (after 12 weeks)
Godin-Shephard Leisure-Time Physical Activity Questionnaire
Time Frame: Pre and post (after 12 weeks)
Questionnaire used to identify self-reported leisure-time physical activity
Pre and post (after 12 weeks)
Age
Time Frame: Pre and post (after 12 weeks)
Age (years)
Pre and post (after 12 weeks)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Danielle Bouchard, University of New Brunswick

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

September 11, 2018

Primary Completion (ANTICIPATED)

April 1, 2021

Study Completion (ANTICIPATED)

April 1, 2021

Study Registration Dates

First Submitted

December 1, 2020

First Submitted That Met QC Criteria

December 17, 2020

First Posted (ACTUAL)

December 22, 2020

Study Record Updates

Last Update Posted (ACTUAL)

February 18, 2021

Last Update Submitted That Met QC Criteria

February 17, 2021

Last Verified

February 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • University Brunswick

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Breast Cancer

Clinical Trials on Exercise Program

Subscribe